Mycobacterial lipoarabinomannan affects human polymorphonuclear and mononuclear phagocyte functions differently

Haematologica

Volumn 85, Issue 1, 2000, Pages 11-18

  Fietta, Anna ^a   Francioli, Cristina ^b   Grassi, Giuliana Gialdroni ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b NONE

Author keywords

AraLAM; Changes in Ca++ (i); Chemotaxis; Macrophages; ManLAM; Monocytes; Phagocytosis; PMNs; Superoxide production

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ARABINOMANNAN; CALCIUM; CALPHOSTIN C; MANNOSE; PROTEIN TYROSINE KINASE; ZYMOSAN;

ARTICLE; CALCIUM CELL LEVEL; CELL FUNCTION; CHEMOTAXIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MONONUCLEAR PHAGOCYTE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTOSIS; PROTEIN SYNTHESIS; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TUBERCULOSIS;

ANTIGENS, BACTERIAL; CALCIUM; CELL CULTURE TECHNIQUES; CHEMOTAXIS; ENZYME ACTIVATION; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MANNOSE; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHAGOCYTOSIS; PROTEIN BIOSYNTHESIS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES;

EID: 0033975436     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Chacterjee D, Lowell K, Rivoire B, Mc Neil M, Brennan PJ. Lipoarabinomannan of Mycobacterium tuberculosis: capping with mannosyl residues in some strains. J Biol Chem 1992; 267:6234-9.
2. Prinzis S, Chatterjee D, Brennan P. Structure and antigenicity of lipoarabinomannan from M. bovis BCG. J Gen Microbiol 1993; 139:2649-58.
3. st ed. Berlin: Springer-Verlag; 1996. p. 1-27.
4. Barnes PF, Chatterjee D, Abrams JS, et al. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol 1992; 149:541-7.
5. Roach TI, Barton CH, Chatterjee D, Blackwell JM. Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-α. J Immunol 1993; 150: 1886-96.
6. Roach TIA, Chatterjee D, Blackwell JM. Induction of early response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infect Immun 1994; 62:1176-84.
7. Roach TI, Barton CH, Chatterjee D, Liew FY, Blackwell JM. Opposing effects of interferon-γ on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages. Immunology 1995; 85:106-13.
8. Yoshida A, Koide Y. Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages. Infect Immun 1997; 65:1953-5.
9. Zhang Y, Doerfler M, Lee TC, Guillemin B, Rom WN. Mechanisms of stimulation of interleukin 1-β and tumor necrosis factor-α by Mycobacterium tuberculosis components. J Clin Invest 1993; 91:2076-83.
10. Zhang Y, Broser M, Cohen H, et al. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest 1995; 95:586-92.
11. Riedel DD, Kaufmann SHE. Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan. Infect Immun 1997; 65:4620-3.
12. Fenton MJ, Vermeulen MW. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun 1996; 64:683-90.
13. Ferguson JS, Gaynor CD, Schlesinger LS. Mononuclear phagocytes in tuberculosis pathogenesis. Curr Opin Infect Dis 1997; 10:190-5.
14. Brown AE, Holzer TJ, Andersen BR. Capacity of human neutrophils to kill Mycobacterium tuberculosis. J Infect Dis 1987; 156:985-9.
15. Hoheisel GB, Tobak L, Teschler H, Erkan F, Kroegel C, Costabel V. Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis. Am J Respir Crit Care 1994; 149:460-3.
16. Jones CS, Amirault HJ, Andersen BR. Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J Infect Dis 1990; 162:700-4.
17. Kurashima K, Mukaida N, Fujimura M, et al. Elevated chemokine levels in bronchoalveolar lavage fluid in tuberculosis patients. Am J Respir Crit Care 1997; 155:1474-7.
18. Newman GW, Guarnaccia JR, Remold HG, Kozanjian PH. Cytokines enhance neutrophils from human immunodeficiency virus-negative donors and AIDS patients to inhibit the growth of Mycobacterium avium in vitro. J Infect Dis 1997; 175:891-900.
19. Ogata K, Luiser BA, Zuberi RI, Ganz T, Lehrer RI, Catanzaro A. Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare. Infect Immun 1992; 60: 4720-5.
20. Okazaki T, Nakahira S, Tani K, Ogushi F, Yasuoka S, Ogura T. Differential cell analysis in bronchoalveolar lavage fluid from pulmonary lesions of patients with tuberculosis. Chest 1992; 102:54-9.
21. Kaplow L. Simplified myeloperoxidase staining using benzidine hydrochloride. Blood 1965; 26:215-9.
22. Colotta F, Peri G, Villa A, Mantovani A. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. J Immunol 1984; 132:936-41.
23. Wilkinson PC. Neutrophil leukocyte function test techniques. In: Thompson RA, ed. Clinical Immunology. Oxford: Blackwell Scientific Publ.; 1977.
24. Grynkewicz G, Poenie M, Tsien RK. A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260:3440-50.
25. Metcalf JA, Gallin JI, Nauseef MW, Root RK. Laboratory manual of neutrophil function. New York: Raven Press; 1986.
26. Preisig E, Hitzig WH. Nitroblue-tetrazolium test for detection of chronic granulomatous disease-Technical modification. Eur J Clin Invest 1971; 1:409-12.
27. 2+ in human neutrophil responses to receptor agonists. Biochem J 1991; 278:705-11.
28. Schlesinger LS, Hull SR, Kaufman TM. Binding of terminal mannosylated units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol 1994; 152:4070-9.
29. Stokes RW, Speert DP. Lipoarabinomannan inhibits monopsonic binding of Mycobacterium tuberculosis to murine macrophages. J Immunol 1995; 155:1361-9.
30. Surgill-Koszycki S, Schlesinger PH, Chakraborty P, et al. Lack of acidification of Mycobacterium phagosomes produced by exclusion of vesicular proton-ATPase. Science 1994; 263:678-81.
31. Venisse A, Fournie JJ, Puzo G. Mannosylated lipoarabinomannan interacts with phagocytes. Eur J Biochem 1995; 231:440-7.
32. Sada E, Brennan PJ, Herrera T, Torres M. Evaluation of lipoarabinomannan for the serological diagnosis of tuberculosis. J Clin Microbiol 1990; 2:2587-90.
33. Bernardo J, Billingslea AM, Blumenthal RL, Seetoo KF, Simons ER, Fenton MJ. Differential responses of human mononuclear phagocytes to mycobacyerial lipoarabinomannans: role of CD14 and the mannose receptor. Infect Immun 1998; 66:28-35.
34. Berman JS, Blumenthal RL, Kornfield H, et al. Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro. J Immunol 1996; 156:3828-35.
35. Ilangumaran S, Arni S, Poincelet M, et al. Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membrane. J Immunol 1995; 155:1334-42.
36. Thelen M, Dewald B, Boggiolini M. Neutrophil signal transduction and activation of respiratory burst. Physiol Rev 1993; 73:797-821.
37. Lopez-Ilasaca M. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem Pharmacol 1998; 56:269-77.
38. Speert DP, Silverstein SC. Phagocytosis of unopsonized-zymosan by human monocyte-derived macrophages: maturation and inhibition by mannose. J Leukocyte Biol 1985; 38:655-59.
39. Stahl PD, Ezekowitz RAB. The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 1998; 10:50-5.